TO REDUCE CELL MEDIA COSTS, INCREASE CELL TISSUE FORMATION
TO SCALE-UP PRODUCTION, INCREASE CELL BIOMASS YIELDS
DEVELOP EFFICIENT HUMAN DISEASE MODELS AND REDUCE PRECLINICAL AND CLINICAL COSTS
TRANSFORM THE ECONOMICS AND
SCALE-UP PRODUCTION
LOW CELL VIABILITY: CELL CULTURE NOT SCALABLE
RAPID LOSS OF PLURIPOTENCY: NOT PROVIDING ALL TISSUES AT LARGE SCALE PRODUCTION
POOR TISSUE FUNCTIONALITY: FAILURE TO CAPTURE COMPLEXITY OF ORGANS
HIGH CELL MEDIA COSTS: MAIN CELL CULTURE COST DRIVER
LACK OF STEM CELL BIG DATA: TO DEVELOP TRUSTWORTHY AI AND PREDICT BEHAVIOUR
Copyright © 2023 Alt Atlas, Stem cells and AI Platform Technology - All rights reserved